Ketorolac Tromethamine Injection — FDA Drug Shortage

Current — Alembic Pharmaceuticals

The FDA lists a drug shortage record for Ketorolac Tromethamine Injection (injection) from Alembic Pharmaceuticals with status Current. The shortage was first posted on Mar 23, 2018.

Shortage details

Status
Current
Company
Alembic Pharmaceuticals
Package NDC
62332-599-25
Dosage Form
Injection
Presentation
Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 62332-599-25)
Initial Posting
Mar 23, 2018

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.